That is necessary, due to the fact that the method a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work. In other words, we have to understand how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error process (biotech stocks). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to produce drugs that do what they're designed to do. This was an advancement practically no one noticed. However it's going to have profound implications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be plenty of financial investment opportunities in this space, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown top stock pick 2021). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps considerably before going higher - future report. I have actually been covering bitcoin for a long time now. One of the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mainly educating readers. But that's not the huge concern anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So think about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. jeff brown stock picks 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are many excellent private companies on the brink of striking the general public markets And I've been working on a new method for you to invest even before these business go public.
This chance has been constructing over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the information. Go right here to reserve your area free of charge.
Emma Walsh here, managing editor of the Diary. Regular Diary readers understand that tech isn't our usual beat (legacy report prediction). And when it concerns tech investing, we leave it to the professionals. Luckily, we have several such experts in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing specialists we understand (biotech stocks jeff brown). In fact, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and forecast what's just around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and far more. These trends are experiencing rapid development and creating incredible chances for investors. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. tech predictions. But despite what many readers might believe, this is a pattern that's just beginning. Although the COVID-19 pandemic interrupted supply chains in 2015, an outstanding 250 million 5G-enabled gadgets were still sold.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (last week). Losing 2 months of production and sales actually impacts the number of 5G devices are sold in the fiscal year. When you think about all of that, offering 250 million systems is amazing. More notably, the hold-ups caused by the pandemic created a lot of pent-up need. And that demand is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G devices will be delivered in 2021 - tech predictions. Which's not my only 5G prediction When I've spoken about 5G in the past, I've described its three various phases.
In Stage 2, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Phase 3, 5G services start to be offered (jeff brown biotech genome sequencing). That's when we start to see applications operating on 5G networks. Consider things like massive multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Stage 3 by this summer. This begins something of a virtuous cycle: The majority of people do not actually appreciate the innovation. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In fact, 5G is going to open up a suite of unbelievable applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment chances going forward will be huge. Stepping far from 5G, the next important technology I foresee in 2021 is CRISPR genetic editing. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR uses a comparable idea but with our genetic code. "Typos" in our genome can cause illness. CRISPR can correct these "typos." For many years, CRISPR was mainly a specific niche technology that wasn't well understood. And throughout that time, there were really only three companies running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating illness and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and delivering incredible returns. This entire industry is successfully a greenfield opportunity.
There's room for numerous business to exist in this area. jeff brown genetic sequencing stock. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or 3 more genetic editing business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things taking place at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software application can properly predict the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That is very important because the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable.
Historically, this has actually been an experimental procedure. And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however a number of drug therapies produced utilizing this technology. This was one of those advancements that nearly nobody discovered. But it's going to have profound ramifications for curing illness. And, naturally, there will be lots of investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it pulled back possibly considerably before going greater. I've been covering bitcoin for a very long time now. Among the very first research study reports I ever published was on bitcoin - future report. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. However at the time of that preliminary recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that question anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. jeff brown top biotech stock 2021. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the information is up to date as of February 2021, but we could not separately validate this claim. Given Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like capability to pick winning technology stocks. He spent more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an outstanding point of view on the marketplace. He's constantly on the hunt for new opportunities, and he shares numerous of his finest choices in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an outstanding credibility as a stock-picker, and he effectively predicted some of the greatest economic events of the past 20 years. Although he does not appear to release his picks to the general public, the service's success is a direct indication of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal whenever, but Jeff Brown's accurate forecasts have made him legions of dedicated followers. That states a lot about his ability. The Future Report is released by Brownstone Research study, a popular financial research study publisher. Brownstone Research study uses numerous research services with a wide range of expertises - jeff brown prediction.
The business is also associated with Bonner & Partners, another well-respected research study publisher - exponential tech investor. On its site, Brownstone states its mission is to supply retail investors with professional-grade research study: "For too long, the very best financial investment research study has actually not been offered to private financiers. It has actually been typically scheduled for financial investment banks, hedge funds, private equity, and high-net-worth clients. biotech stocks. The objective of Brownstone Research is to make that sort of exclusive research readily available to any investors looking to gain an edge in the marketplaces. The goal is easy to deliver special and successful investment research found nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise works as the company's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After years of stable success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout most of America. If you know even a bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. jeff brown 1 biotech company. Everything he touches relies on gold! Jeff is well aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown thinks S.A.V. artificial intelligence. might be "the greatest pattern of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding 2 innovative innovations: expert system and electric automobiles. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing brief of the automotive industry's Holy Grail. As you know, electric cars and self-driving vehicle stocks have actually been huge this year, however the Wall Street device has actually approved buzz without much tangible result. In spite of a drastic boost in competitors over the previous couple of years, Brown still thinks Musk has the very best chance of putting all of it together.
tech could be the magic string that ties all of it together. S.A.V. means Shared Autonomous Vehicle, and it might be the future of transport. Basically, this technology would enable you to rent out your car as a self-governing, self-driving taxi when you're not utilizing it. You simply get out of the vehicle and press a button on an app that tells the vehicle to "join the fleet." Next thing you know, you're unwinding on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a hefty chunk of the earnings. It sounds insane, however it could be closed than you believe.